Home > Compound List > Product Information
Albendazole sulfone_Molecular_structure_CAS_75184-71-3)
Click picture or here to close

Albendazole sulfone

Catalog No. Bio-0400 Name InterBioScreen
CAS Number 75184-71-3 Website http://www.ibscreen.com
M. F. C12H15N3O4S Telephone +7 49652 40091
M. W. 297.3302 Fax
Purity Email screen@ibscreen.chg.ru
Storage Chembase ID: 157693

SYNONYMS

IUPAC name
methyl N-[5-(propane-1-sulfonyl)-1H-1,3-benzodiazol-2-yl]carbamate
IUPAC Traditional name
methyl N-[5-(propane-1-sulfonyl)-1H-1,3-benzodiazol-2-yl]carbamate
Synonyms
Alben
Valbazen
Helmintal
Zentel
Bermosol
Eskazole

DATABASE IDS

CAS Number 75184-71-3

PROPERTIES

Application(s) Anthelmintic
Application(s) Investigated for treatment of chronic stronglyoidiasis, and for microsporidiosis in AIDS patients
Mechanism of Action Causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin,
Mechanism of Action thus inhibiting its polymerization or assembly into microtubules.
Mechanism of Action The loss of the cytoplasmic microtubules leads to impaired uptake of glucose by the larval and adult stages of the susceptible parasites, and depletes their glycogen stores.
Mechanism of Action Degenerative changes in the endoplasmic reticulum, the mitochondria of the germinal layer, and the subsequent release of lysosomes result in decreased production of adenosine triphosphate (ATP),
Mechanism of Action which is the energy required for the survival of the helminth.
Mechanism of Action Due to diminished energy production, the parasite is immobilized and eventually dies.
Mechanism of Action Also has been shown to inhibit the enzyme fumarate reductase, which is helminth-specific.
Mechanism of Action This action may be considered secondary to the effect

DETAILS

REFERENCES

  • U.S. Pat., 1975, SmithKline, 3 915 986; CA, 84, 31074r, (synth, pharmacol)
  • Theodorides, V.J. et al., Experientia, 1976, 32, 702, (pharmacol)
  • Bogan, J.A., Drugs of Today (Barcelona), 1979, 15, 87, (rev)
  • Gyurik, R.J. et al., Drug Metab. Dispos., 1981, 9, 503, (metab)
  • Bochis, R.J. et al., J. Med. Chem., 1981, 24, 1518, (props)
  • Firth, M., Int. Congr. Symp. Ser. R. Soc. Med., (Ed.), No. 61, 1984, (book)
  • Delatour, P. et al., Xenobiotica, 1991, 21, 217, (metab)
  • Martindale, The Extra Pharmacopoeia, 30th edn., Pharmaceutical Press, 1993, 38
  • Archibald, L.K. et al., Quart. J. Med., 1993, 86, 191, (use)
  • Negwer, M., Organic-Chemical Drugs and their Synonyms, 7th edn., Akademie-Verlag, 1994, 2970, (synonyms)
  • Oldfield, E.C., Am. J. Gastroenterol., 1995, 90, 159, (use)
  • Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, VAD000